You need to enable JavaScript to run this app.
Recon: AstraZeneca COVID vaccine 79% effective in US trial; FDA raises safety concerns ahead of tanezumab adcomm
Recon
Michael Mezher
ReconMichael Mezher
ReconMichael Mezher